Results 111 to 120 of about 24,744 (229)

Effect of thermosonication on the UHPLC‐QTOF‐IMS‐based metabolomic profile of orange juice

JSFA reports, Volume 6, Issue 8, Page 309-313, August 2026.
Abstract Background This study investigated the impact of thermosonication on the metabolomic profile of orange juice to understand processing‐induced alterations in bioactive compounds and quality attributes. Results Moderate thermosonication at 45°C preserved structural siloxanes and certain amino acids, whereas higher temperatures between 60 and 75 ...
Deepti Kothari, Arun Kumar, Saloni Joshi, Desta Dugassa Fufa, Sajad Ali   +4 more
wiley   +1 more source

Comparative effects of second-line oral antidiabetic medications on atrial fibrillation risk in patients with type 2 diabetes: a nationwide retrospective cohort study. [PDF]

Cardiovasc Diabetol
Heo GY, Heo SJ, Ko B, Ko YE, Koh HB, Park CH, Park JT, Han SH, Yoo TH, Kang SW, Han M, Kim HW.   +11 more
europepmc   +1 more source

Type 2 Diabetes Mellitus: Molecular Pathogenesis and Therapeutic Interventions

MedComm, Volume 7, Issue 8, August 2026.
This graphical summary illustrates the multiorgan therapeutic landscape for Type 2 diabetes mellitus (T2D), integrating molecular pathogenesis with modern treatment strategies. It depicts how current interventions, including SGLT2 inhibitors, GLP‐1 receptor agonists, and insulin secretagogues, target key organs—kidney, pancreas, gastrointestinal tract,
Shinuan Fei, Xiyue Xiong, Lu Zhang, Jian Zhang, Lawrence W. C. Chan, Hong Jiang, Qingqing Xiong, Changtao Hu, Jie Chen, Sijun Yang   +9 more
wiley   +1 more source

Comparative risk of the neurodegenerative outcomes between sodium-glucose co-transporter 2 (SGLT2) inhibitors and thiazolidinediones in type 2 diabetes: a multicentre cohort study using the Korean healthcare database (2014-2025). [PDF]

BMJ Open
Park SJ, Kim HJ, Seo M, Byun DW, Suh K, Yoo MH, Yang H, Lee I, Kwon SH, Kim M, Mok JO, Kim DY, Sohn SY, Park RW, Seo WW, Kwon SY, Rhee SY, Kwon JM, Cha JM, Park HK.   +19 more
europepmc   +1 more source

Citrus Peel Xanthophylls Orchestrate Lipid–Glucose–Inflammation Axis Reprogramming in Cardiometabolic Syndrome: Integrative In Silico and In Vivo Evidence

Molecular Nutrition &Food Research, Volume 70, Issue 15, 17 August 2026.
Central obesity and dyslipidaemia converge to impair insulin signalling and trigger chronic inflammation, oxidative stress, and mitochondrial dysfunction. This integrated metabolic disruption drives lipid imbalance, apoptosis, and persistent hyperglycaemia, ultimately accelerating the progression of type 2 diabetes and cardiovascular disease.
Muhammad Reva Aditya, Muhammad Yusuf, Kanandya Kizzandy, Rizki Hari Mulia, Agnes Vianne, Athaya Rahmanardi Muhammad, Davina Shafa Aviantiputri, Adha Fauzi Hendrawan, Ade Meidian Ambari, Dante Saksono Harbuwono, Antonello Santini, Fahrul Nurkolis   +11 more
wiley   +1 more source

Antidiabetic drug and chronic respiratory disease in type 2 diabetes: a network meta-analysis and Mendelian randomization analysis. [PDF]

Ther Adv Endocrinol Metab
Patel I, Chai YH, Wang ZQ, Xu H, Zhang JY, Simo R, Tang XY, Zhou JB.   +7 more
europepmc   +1 more source

A Remote Program for Navigator‐ and Pharmacist‐Led Management of Obesity Medications in Adults: Rationale, Design, and Implementation

Obesity Science &Practice, Volume 12, Issue 4, August 2026.
ABSTRACT Objective Remote interventions leveraging team‐based care may ameliorate persistent gaps in obesity medication implementation, but prospective studies are lacking. In this paper, the design, enrollment, and implementation of a remote intervention for obesity medications are described.
Bryn Falahee, John W. Ostrominski, Kavishwar B. Wagholikar, Ozan Unlu, David Zelle, Sanjay Kumar, Daniel Gabovitch, Michela Tucci, Austen Smith, Hunter Nichols, Irene G. McCarthy, Samar Mushtaque, Tabitha V. Rutkowski, Ashley C. McCarthy, Heather J. Baer, Christopher P. Cannon, Naomi D. L. Fisher, Jorge Plutzky, Caroline M. Apovian, Benjamin M. Scirica, Alexander J. Blood   +20 more
wiley   +1 more source

Outcomes of oral antidiabetic drugs in metabolic dysfunction-associated steatotic liver disease: a nationwide target trial emulation study. [PDF]

Clin Mol Hepatol
Jang H, Kim Y, Lim YK, Lee DH, Joo SK, Koo BK, Kim GA, Lee W, Romeo S, Kim W, Innovative Target Exploration of NAFLD (ITEN) consortium.   +10 more
europepmc   +1 more source

Secular Trend in Glycaemic Management in Type 2 Diabetes Patients With and Without Cirrhosis Between 2000 and 2023: A Territory‐Wide Cohort Study

Alimentary Pharmacology &Therapeutics, Volume 64, Issue 3, Page 356-366, August 2026.
In this territory‐wide cohort study, improving glycemic control can be observed regardless of cirrhosis status. Oral antidiabetic medication was more often used in the non‐cirrhosis group, and insulin was preferred in patients with decompensated cirrhosis, who exhibited an increasing incidence of hypoglycemia over the years and need individualized ...
Mary Yue Wang, Sherlot Juan Song, Nana Peng, Grace Lai‐Hung Wong, Vincent Wai‐Sun Wong, Jimmy Che‐To Lai, Terry Cheuk‐Fung Yip   +6 more
wiley   +1 more source

Comparative Longitudinal Evaluation of Systemic Inflammatory Markers in Type 2 Diabetes Treated with Four Oral Antidiabetic Drug Classes. [PDF]

J Clin Med
Yamak M, Çakır S, Uzun S, Cebeci E, Menken Ö, Ozturk S.   +5 more
europepmc   +1 more source